A comprehensive review of protein kinase inhibitors for cancer therapy
Author:
Affiliation:
1. Department of Internal Medicine, University of Arizona College of Medicine at South Campus, Tucson, AZ, USA
2. Division of Hematology-Oncology, University of Arizona Cancer Center, Tucson, AZ, USA
Funder
National Cancer Institute
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1527688
Reference176 articles.
1. Evolution of protein kinase signaling from yeast to man
2. The Protein Kinase Complement of the Human Genome
3. Structural Basis for Control by Phosphorylation
4. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA
5. Oncogenic Kinase Signaling in Human Neoplasms
Cited by 161 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Precision medicine: success stories and challenges from science to implementation;The New Era of Precision Medicine;2024
2. Disparities in dosing, drug reduction, and drug discontinuation among US FDA approved tyrosine kinase inhibitors;F1000Research;2023-11-24
3. Identification of mitogen‐activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies;Journal of Molecular Recognition;2023-11-13
4. New Thiazolyl-Pyrazoline Derivatives as Potential Dual EGFR/HER2 Inhibitors: Design, Synthesis, Anticancer Activity Evaluation and In Silico Study;Molecules;2023-11-06
5. Inhibition of KIT for chronic urticaria: a status update on drugs in early clinical development;Expert Opinion on Investigational Drugs;2023-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3